PXD004444 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | A novel treatment for glioblastoma based on Taxol activation of PC1/3-depleted macrophages: evidence from a proteomic and functional study. |
Description | Tumor-associated macrophages contribute to tumor pathogenesis and represent an attractive therapeutic target. We report that the proprotein convertase PC1/3 inhibits the TLR4 Myd88-pathway induced in macrophages by the anti-cancer agent Taxol. Thus, PC1/3 knock-down in these cells exacerbates the TLR4 MyD88-dependent pathway triggered by Taxol. In PC1/3 knock-down macrophages, Taxol drives the secretion of pro-inflammatory cytokines, inhibits STAT3 signaling and counteracts tumor-supportive activities, thus inhibiting viability, growth and invasion of glioblastoma cells. Proteomic analyses indicate that their secretomes are characterized by a unique protein profile supporting a specific paracrine anti-tumoral effect. These findings unravel the potential value of a new therapeutic strategy combining PC1/3 inhibition and activation of the TLR4 MyD88-dependent pathway to switch intra-tumoral macrophages toward an anti-tumoral immunophenotype. |
HostingRepository | PRIDE |
AnnounceDate | 2018-03-19 |
AnnouncementXML | Submission_2018-03-19_04:17:07.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Maxence Wisztorski |
SpeciesList | scientific name: Rattus norvegicus (Rat); NCBI TaxID: 10116; |
ModificationList | monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2016-06-27 04:03:42 | ID requested | |
⏵ 1 | 2018-03-19 04:17:09 | announced | |
Publication List
Duhamel M, Rose M, Rodet F, Murgoci AN, Zografidou L, R, é, gnier-Vigouroux A, Vanden Abeele F, Kobeissy F, Nataf S, Pays L, Wisztorski M, Cizkova D, Fournier I, Salzet M, Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies. Mol Cell Proteomics, 17(6):1126-1143(2018) [pubmed] |
Keyword List
curator keyword: Biological, Biomedical |
submitter keyword: Proprotein convertase PC1/3, Taxol, STAT3, TLR4 signaling, calcium, intracellular trafficking, macrophage, shotgun proteomic, tumors |
Contact List
Michel Salzet |
contact affiliation | Univ. Lille, Inserm, U-1192 - Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000 Lille, France |
contact email | michel.salzet@univ-lille1.fr |
lab head | |
Maxence Wisztorski |
contact affiliation | Université Lille 1 |
contact email | maxence.wisztorski@univ-lille1.fr |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/03/PXD004444 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD004444
- Label: PRIDE project
- Name: A novel treatment for glioblastoma based on Taxol activation of PC1/3-depleted macrophages: evidence from a proteomic and functional study.